We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Rogue produces indulgent preserves by using traditional cooking methods to make luxury preserves with a provocative twist. Their aim is to be the UK's best-selling and most popular preserve brand. Rogue started working with a SALSA accredited manufacturer, that can produce the products at scale and delivers stock to their first major UK distributor. They have featured on BBC Radio Wales following a successful Royal Welsh Agricultural Show. With the proceeds, they are going to spend on marketing, scaling up their business, and planning to build a strong management team.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £29,224
Candy Kitten are a confectionary company that were built to modernise the confectionary industry by introducing new flavours and a higher quality product than those currently available.
days to go: Expired investment: £161,016
Tap Coffee have been trading for the last 5 years and have been profitable for the last 3. They roast, retail, wholesale and sell their coffee online. Currently Tap Coffee have 3 busy coffee stores located in central London. 
days to go: Expired investment: £86,510
SL'M is the world's first zero sugar, zero carb, zero fat range of wines which is approved by both the TSO and FSA. During COVID-19, the company witnessed record earnings, amidst profitable online sales in March 2020. The company has also been featured in publications such as Cosmopolitan, The Sun, and many more. Slim Wine's audience comprises Gen X, Millennials, and Boomers, giving the company a great cross-generational position in the market. The company has served over 2 million glasses of wine and generated profits of over £1 million amidst a growing customer base. Slim Wine's latest vintage, Cuvée 450, was showcased at the 'Royal Berkshire Polo Club'. The company will use the investment to boost sales and marketing, advertising campaigns, and wine production.

Pitch Rated

46%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £262,948
Stroodles are straws made from pasta, which eliminates the use of plastic and wet paper straws. It lasts over 1 hour, is tasteless, 100% biodegradable and edible. The company has received worldwide brand exposure through viral content via Unilad and BBC. It has B2B and B2C clients including Marriott and Ibis in Europe, and it has stockists in the UK and Austria. The company will use the funds to scale marketing and sales and to become the market leader in the straw market.
days to go: Expired investment: £214,980
Mute International aim to make electric scooters and bicycles immediately available for use through their technology driven usership programmes. The bike supply programs are tailored to individual and commercial needs without the constraints and costs of ownership whilst also making a difference to the environment. 
days to go: Expired investment: £749,660
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph